Discover trends, market shifts, and competitive outlooks for the rat model industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Rat Model Market Through 2034?

The rat model industry has been experiencing a robust growth lately. It is predicted to escalate from $1.65 billion in 2024 to $1.77 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.4%. The expansion in the previous years can be tied to the escalating demand for preliminary research, increased investment by the government, research requirements, pharmaceutical development drives, and an upswing in chronic diseases.

The market for rat models is anticipated to experience considerable growth in the coming years, projected to reach “$2.56 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.8%. This expected growth during the forecasted period can be linked to the increased use of personalized medicine, the rising demand for animal models in developing new drugs, a heightened emphasis on disease prevention, the growth of the biopharmaceutical industry, advances in imaging technologies, and funding from both government and private entities. The forecast period is also expected to see significant global research collaborations, advancements in imaging technology, the implementation of omics technologies, progress in genome editing methods, the escalating significance of rat models in disease research, and the emergence of personalized medicine and bespoke rat models.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10100&type=smp

What are the Fundamental Drivers and Innovations Shaping the Rat Model Market?

The increase in chronic disease cases is anticipated to propel the rat model market’s expansion. Chronic illnesses are those that persist for a year or more, interferes with daily activities or necessitates consistent medical attention. Rat models serve a crucial role in our understanding of chronic infection’s pathogenesis, immunological reactions, and therapy, offering critical knowledge that aids in the formation of new treatments and interventions. For example, data from the World Health Organization, a Switzerland-based division of the United Nations, revealed in September 2023, that there were 41 million fatalities accounting for 74% of the total attributed to non-communicable or chronic diseases every year across the globe. Consequently, the ascending prevalence of chronic diseases is propelling the rat model market’s growth.

How Is the Rat Model Market Segmented?

The rat model market covered in this report is segmented –

1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned

2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services

3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies

4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications

Subsegments:

1) By Knockout: CRISPR Knockout, Traditional Knockout

2) By Outbred: Sprague Dawley, Long-Evans, Wistar

3) By Inbred: Fischer 344, Lewis, Buffalo

4) By Hybrid: F1 Hybrid, F2 Hybrid

5) By Immunodeficient: Nude Rats, SCID Rats

6) By Conditioned: Obese Rats, Diabetic Rats

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10100&type=smp

Which Regions Are Driving the Next Phase of the Rat Model Market Growth?

North America was the largest region in the rat model market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Rat Model Market?

Key players in the rat model market are forging alliances for preclinical investigation in oncology and other therapy fields. These partnerships with rat model firms allow them to concentrate on their primary operations and make the most out of the efficiency and cost-effectiveness of these speciality service providers that have secure infrastructure and resources for creating rat models. As an example, in March 2022, a biotech firm based in the US, Hera BioLabs, entered a partnership with Charles River Laboratories, International Inc., a US pharmaceutical company for the commercialization of Hera’s SRG rat, or OncoRat. In this partnership, Charles River is responsible for the breeding, distribution, sale, and marketing of the SRG rat to the preclinical research world. The SRG rat is a prominent immunodeficient rat, thereby making it perfect for xenograft or PDX studies, offering unique benefits against mouse models when carrying out in vivo efficacy evaluation of probable cancer treatments. This model circumvents the restrictions of smaller mouse models, permitting larger tumor growth, simpler surgeries, and the availability of more tissues and serum for analysis, including recurring sampling.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

How Is the Rat Model Market Defined and What Are Its Core Parameters?

The rat model refers to a process that uses rat functional genes, cells, tissues, and organs. These mouse models are employed to simulate both pathological and healthy conditions of the human immune system. The use of humanized rat models is crucial for preclinical research since they may be used to simulate human disease states, evaluate the effectiveness of compounds, and examine how they affect human proteins.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10100

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model